A R T I C L E S
Canard et al.
Table 4. Fitted Microscopic Thermodynamic Parameters for [Mm(L8)]mz+ (m ) 1, 2, z ) 2, 3) and [M(L2)n]z+ (n ) 1-3, z ) 2, 3;
Simultaneous Linear Least-Squares Fits of Eqs 11, 14-16, Acetonitrile + 0.01 M (nBu)4NClO4, 298 K)a
microscopic parameters
Ca
La
Eu
Lu
Lub
log(fMN3)/∆GiMnter (kJ/mol)
log(fMN3 ‚ ceff)/∆GMintra (kJ/mol)
log(ceff)/∆GcMorr (kJ/mol)
log(uL.L)/∆EL,L (kJ/mol)
log(uM,M)/∆EM,M (kJ/mol)
AFc
3.8(2)/-21(1)
2.2(4)/-12(4)
-1.6(2)/9(1)
-0.2(2)/1(1)
-
6.3(2)/-35(1)
1.5(2)/-8(1)
-4.8(2)/27(1)
-0.9(2)/5(1)
-
8.7(3)/-49(2)
1.4(2)/-8(1)
-7.3(3)/39(2)
-1.8(3)/10(2)
-
9.15(8)/-51.3(5)
1.52(8)/-8.5(4)
-7.63(8)/42.8(4)
-1.74(9)/9.8(5)
-
9.15(8)/-51.3(5)
1.52(8)/-8.5(4)
-7.63(8)/42.8(4)
-1.74(9)/9.8(5)
-7.4(2)/42(1)
0.003
0.014
0.012
0.012
0.003
b
c
a The uncertainties correspond to those obtained during the multilinear least-square fit processes. Fitted with eqs 11, 12, 14-16; see text. Agreement
factor AF ) (∑ (log(âexp)-log(âci alcd))2)/(∑i(log(âei xp))2).
x
i
i
Preparation of Pyridine-2,6-dicarboxylic Acid 2-[Ethyl-(4-meth-
oxymethyl-2-nitro-phenyl)-amide] 6-[Ethyl-(4-methyl-2-nitro-phen-
yl)-amide] (9). A mixture of 6-[ethyl-(4-methyl-2-nitro-phenyl)-
carbamoyl]-pyridine-2-carboxylic acid (6, 0.68 g, 2.1 mmol), CH2Cl2
(5 mL), thionyl chloride (1.4 mL, 20 mmol, 10 equiv) and DMF (10
µL) was refluxed for 1.5 h under a nitrogen atmosphere and evaporated
to dryness. The yellow residue was dried under vacuum for 1 h and
then dissolved in CH2Cl2 (3 mL). A solution of ethyl-(4-methoxymethyl-
2-nitro-phenyl)amine (8, 0.42 g, 2.0 mmol) and triethylamine (0.3 mL,
2.0 mmol) in CH2Cl2 (3 mL) was then added dropwise. The mixture
was stirred at room temperature for 30 min, refluxed for 1 h washed
with aq. half-sat. NH4Cl (2 × 10 mL), dried over MgSO4, and
evaporated to yield a brown oil, which was purified by column
chromatography (silicagel, CH2Cl2/MeOH 100:0 f 97:3) to afford 9
as a beige solid (1.0 g, 1.9 mmol, 96%). 1H NMR ((CD3)2SO, 440 K):
δ ) 1.10 (m, 6H; CH3(Et)), 2.37 (s, 3H; Ar-CH3), 3.34 (m, 3H; OCH3),
3.70 (m, 4H; CH2(Et)), 4.48 (s, 2H; Ar-CH2O), 7.27 (m, 1H; Ar-H),
mmol) was stirred for 16 h at room temperature and poured into an
ice-cooled aq. 1 M KOH (400 mL). The aqueous layer was extracted
with CH2Cl2 (2 × 10 mL). The combined organic phases were washed
with deionized water until neutral, dried over Na2SO4, filtered, and
evaporated to dryness to afford the crude acetate, which was dissolved
in methanol (80 mL) and aq. 1 M KOH (50 mL) and stirred for 15 h
at room temperature. The methanol was distilled under vacuum, and
the resulting solution was poured into brine (150 mL) and extracted
with CH2Cl2 (4 × 30 mL). The combined organic phases were washed
with deionized water until neutral, dried over MgSO4, filtered, and
evaporated to dryness. The resulting crude compound was purified by
column chromatography (silicagel, CH2Cl2/MeOH 98:2 f 94:6) to
afford 11 as a white solid (0.57 g, 1.38 mmol, 99%). 1H NMR
3
3
(CDCl3): δ ) 1.37 (t, J ) 7.2 Hz, 3H; CH3 (Et)), 1.39 (t, J ) 7.2
3
Hz, 3H; CH3 (Et)), 2.55 (s, 3H; Ar-CH3), 4.79 (q, J ) 7.2 Hz, 2H;
CH2 (Et)), 4.81 (q, 3J ) 7.2 Hz, 2H; CH2 (Et)), 4.86 (s, 2H; Ar-
CH2O), 7.22 (dd, 3J ) 8.3 Hz, 4J ) 1.4 Hz, 1H; Ar-H), 7.39 (d, 3J )
3
3
4
7.38 (m, 1H; Ar-H), 7.46-7.48 (m, 3H; Ar-H), 7.62 (d, J ) 7.0
8.3 Hz, 1H; Ar-H), 7.43 (dd, J ) 8.3 Hz, J ) 1.4 Hz, 1H; Ar-H),
3
Hz, 1H; Ar-H), 7.75 (s, 1H; Ar-H), 7.81 (m, 1H; Ar-H), 7.87 ppm
(s, 1H; Ar-H); ESI-MS (CH2Cl2/MeOH 9:1): 522.5 [M + H+].
Preparation of 6-(1-Ethyl-5-methoxymethyl-1H-benzoimidazol-
2-yl)-2-(1-ethyl-5-methyl-1H-benzoimidazol-2-yl)-pyridine (10). To
a solution of pyridine-2,6-dicarboxylic acid 2-[ethyl-(4-methoxymethyl-
2-nitro-phenyl)-amide] 6-[ethyl-(4-methyl-2-nitro-phenyl)-amide] (9,
2.48 g, 4.75 mmol) in ethanol/water (315 mL/95 mL), activated iron
powder (4.25 g, 75.8 mmol) and concentrated hydrochloric acid (37%,
11.6 mL, 138.6 mmol) were added. The mixture was refluxed for 18
h under nitrogen, the excess of iron was filtered off, and ethanol was
distilled under vacuum. The resulting mixture was poured into CH2Cl2
(100 mL), Na2H2EDTA‚2H2O (51 g, 137 mmol) in water (250 mL)
was added, and the resulting stirred mixture was neutralized (pH 7.0)
with concentrated aqueous NH4OH solution. Concentrated H2O2
solution (30%, 2.7 mL, 27 mmol) was added under vigorous stirring,
and the pH was adjusted to 8.5 with aqueous NH4OH solution. After
15 min, the organic layer was separated and the aqueous phase was
extracted with CH2Cl2 (3 × 50 mL). The combined organic phases
were washed with water until neutral, dried over Na2SO4, and
evaporated to dryness. The crude residue was purified by column
chromatography (silicagel, CH2Cl2/MeOH 100:0 f 97:3) to afford 10
7.48 (d, J ) 8.3 Hz, 1H; Ar-H), 7.69 (s, 1H; Ar-H), 7.82 (s, 1H;
3
3
Ar-H), 8.01 (t, J ) 7.9 Hz, 1H; Ar-H), 8.31 ppm (d, J ) 7.9 Hz,
2H; Ar-H); ESI-MS (CH2Cl2/MeOH 9:1): 412.5 [M + H+].
Preparation of 6-(5-Chloromethyl-1-ethyl-1H-benzoimidazol-2-
yl)-2-(1-ethyl-5-methyl-1H-benzoimidazol-2-yl)-pyridine (12). A mix-
ture of {1-ethyl-2-[6-(1-ethyl-5-methyl-1H-benzoimidazol-2-yl)-pyridin-
2-yl]-1H-benzoimidazol-5-yl}-methanol (11, 1.02 g, 2.48 mmol),
CH2Cl2 (40 mL) and thionyl chloride (1.8 mL, 25 mmol) was stirred
for 16 h at room temperature; it was then poured into aq. sat. NaHCO3
(400 mL). The aqueous layer was extracted with CH2Cl2 (3 × 20 mL),
and the combined organic phases were washed with deionized water
until neutral, dried over MgSO4, filtered, and evaporated to dryness.
The resulting crude compound was purified by column chromatography
(silicagel, CH2Cl2/MeOH 100:0 f 98:2) to afford 12 as a white solid
1
3
(0.89 g, 2.07 mmol, 83%). H NMR (CDCl3): δ ) 1.38 (t, J ) 7.2
3
Hz, 3H; CH3 (Et)), 1.39 (t, J ) 7.2 Hz, 3H; CH3 (Et)), 2.55 (s, 3H;
Ar-CH3), 4.80 (m, 4H; CH2 (Et)), 4.82 (s, 2H; Ar-CH2Cl), 7.23 (dd,
4
3
3J ) 8.4 Hz, J ) 1.1 Hz, 1H; Ar-H), 7.39 (d, J ) 8.4 Hz, 1H;
Ar-H), 7.45 (dd, 3J ) 8.4 Hz, 4J ) 1.6 Hz, 1H; Ar-H), 7.50 (d, 3J )
8.4 Hz, 1H; Ar-H), 7.69 (s, 1H; Ar-H), 7.89 (s, 1H; Ar-H), 8.08 (t,
3J ) 7.9 Hz, 1H; Ar-H), 8.34 (dd, J ) 7.9 Hz, J ) 1.0 Hz, 1H;
Ar-H), 8.38 ppm (d, 3J ) 7.9 Hz, 1H; Ar-H); ESI-MS (CH2Cl2/MeOH
9:1): 430.4 [M + H+].
3
4
1
as a white solid (1.93 g, 4.53 mmol, 95%). H NMR (CDCl3): δ )
3
3
1.37 (t, J ) 7.2 Hz, 3H; CH3 (Et)), 1.38 (t, J ) 7.2 Hz, 3H; CH3
(Et)), 2.55 (s, 3H; Ar-CH3), 3.44 (s, 3H; OCH3), 4.65 (s, 2H; Ar-
Preparation of Thioacetic Acid S-{1-Ethyl-2-[6-(1-ethyl-5-methyl-
1H-benzoimidazol-2-yl)-pyridin-2-yl]-1H-benzoimidazol-5-ylmeth-
yl} Ester (13). 6-(5-Chloromethyl-1-ethyl-1H-benzoimidazol-2-yl)-2-
(1-ethyl-5-methyl-1H-benzoimidazol-2-yl)-pyridine (12, 500 mg, 1.16
mmol) was dissolved in a suspension of potassium thioacetate (797
mg, 6.97 mmol, 6 equiv) in acetone (15 mL) and dichloromethane (15
mL). The mixture was stirred and heated at 55 °C for 16 h and then
evaporated to dryness. The resulting solid was dissolved in ethyl acetate
(20 mL) and water (20 mL). The aqueous phase was separated and
extracted with ethyl acetate (2 × 30 mL). The combined organic phases
were washed with brine, dried over Na2SO4, and evaporated to yield a
3
4
CH2O), 4.81 (m, 4H; CH2 (Et)), 7.22 (dd, J ) 8.3 Hz, J ) 1.4 Hz,
1H; Ar-H), 7.40 (m, 2H; Ar-H), 7.49 (d, J ) 8.3 Hz, 1H; Ar-H),
7.68 (s, 1H; Ar-H), 7.84 (s, 1H; Ar-H), 8.07 (t, J ) 7.9 Hz, 1H;
3
3
Ar-H), 8.36 ppm (m, 2H; Ar-H); ESI-MS (CH2Cl2/MeOH 9:1): 426.0
[M + H+].
Preparation of {1-Ethyl-2-[6-(1-ethyl-5-methyl-1H-benzoimida-
zol-2-yl)-pyridin-2-yl]-1H-benzoimidazol-5-yl}-methanol (11). A
mixture of 6-(1-ethyl-5-methoxymethyl-1H-benzoimidazol-2-yl)-2-(1-
ethyl-5-methyl-1H-benzoimidazol-2-yl)-pyridine (10, 0.6 g, 1.4 mmol)
in acetic anhydride/CH2Cl2 (10 mL/10 mL) and BF3‚Et2O (0.9 mL, 7
9
1038 J. AM. CHEM. SOC. VOL. 130, NO. 3, 2008